Centrum Medyczne UNO-MED

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease1 trial
• Macular degeneration1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• EyePoint Pharmaceuticals, Inc.1 trial
• Shanghai Henlius Biotech1 trial

Running trials

• Active, not recruiting

  COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  NCT07449936· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

Closed trials

• Completed

  A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT04740671· Phase 3· Shanghai Henlius Biotech· Source